(en) Over the last decade, the management of advanced and metastatic prostate cancer (PCa) has remarkably evolved from a disease treated primarily by androgen deprivation therapy(ADT) into a complex landscape with now multiple therapies with demonstrated survival benefit. […]
Tombal, B., & Beltran, H. (2022). Editorial: Metastatic prostate cancer: a wealth of data to put into practice. Current Opinion in Urology, 32(3), 267-268. https://doi.org/10.1097/MOU.0000000000000992 (Original work published 2022)